GF Fund Management CO. LTD. Boosts Holdings in Axon Enterprise, Inc (NASDAQ:AXON)

GF Fund Management CO. LTD. lifted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 28.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,096 shares of the biotechnology company's stock after purchasing an additional 2,261 shares during the quarter. GF Fund Management CO. LTD.'s holdings in Axon Enterprise were worth $5,310,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in AXON. Fourth Dimension Wealth LLC bought a new position in Axon Enterprise in the 4th quarter valued at about $30,000. Bartlett & CO. Wealth Management LLC boosted its position in shares of Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after buying an additional 33 shares during the last quarter. Alpine Bank Wealth Management bought a new stake in Axon Enterprise during the first quarter worth $40,000. Elequin Capital LP purchased a new stake in Axon Enterprise in the 4th quarter valued at $46,000. Finally, CoreFirst Bank & Trust purchased a new stake in Axon Enterprise in the 4th quarter valued at $59,000. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Price Performance

Shares of AXON traded up $20.93 during trading hours on Friday, reaching $795.48. 268,670 shares of the company's stock traded hands, compared to its average volume of 540,118. Axon Enterprise, Inc has a 12 month low of $279.02 and a 12 month high of $830.21. The company has a current ratio of 2.83, a quick ratio of 2.62 and a debt-to-equity ratio of 0.68. The stock has a market cap of $61.93 billion, a PE ratio of 192.14, a price-to-earnings-growth ratio of 91.57 and a beta of 1.29. The firm's 50 day simple moving average is $736.97 and its 200-day simple moving average is $635.79.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. The business had revenue of $603.63 million during the quarter, compared to analysts' expectations of $585.67 million. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The business's quarterly revenue was up 31.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.15 EPS. Equities analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Wall Street Analyst Weigh In

AXON has been the subject of several analyst reports. Bank of America increased their price objective on shares of Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a research note on Wednesday, June 4th. Needham & Company LLC boosted their price objective on Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a research report on Thursday, May 8th. Barclays raised their target price on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. The Goldman Sachs Group boosted their price target on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a report on Wednesday, May 14th. Finally, Craig Hallum downgraded Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. One analyst has rated the stock with a sell rating, one has issued a hold rating and ten have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $699.55.

Insider Activity at Axon Enterprise

In other news, CFO Brittany Bagley sold 3,400 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $700.00, for a total value of $2,380,000.00. Following the sale, the chief financial officer directly owned 131,833 shares in the company, valued at approximately $92,283,100. This trade represents a 2.51% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Joshua Isner sold 9,905 shares of the stock in a transaction dated Wednesday, May 21st. The stock was sold at an average price of $738.03, for a total transaction of $7,310,187.15. Following the completion of the transaction, the president directly owned 298,809 shares of the company's stock, valued at approximately $220,530,006.27. The trade was a 3.21% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 44,642 shares of company stock worth $30,500,428 in the last 90 days. Corporate insiders own 4.40% of the company's stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.